Center of Excellence in Eliminating Disparities
消除不平等卓越中心
基本信息
- 批准号:8059107
- 负责人:
- 金额:$ 140万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-31 至 2013-07-30
- 项目状态:已结题
- 来源:
- 关键词:AdherenceBreastCapitalCaringChicagoClinical Practice GuidelineDataDevelopmentDiagnosisDiagnosticEffectivenessEvaluationHospitalsInterventionMammographyMedically Underserved AreaNational Comprehensive Cancer NetworkOutcomes ResearchPatientsRandomized Clinical TrialsResearchResearch InfrastructureResearch Project GrantsResearch TrainingResolutionScreening ResultServicesTimeTrainingWomanWorkbasecancer carecomparative effectivenesscompliance behaviordissemination researcheffectiveness researchfollow-upmalignant breast neoplasmprimary outcomestandard of care
项目摘要
DESCRIPTION (provided by applicant): This competitive revision application supports the development of Comparative Effectiveness Research for Eliminating Disparities (CERED), which includes four CERED cores: Research, Training, Data Infrastructure, and Dissemination. The research project objective is to evaluate the effectiveness of a hospital-based patient navigation intervention strategy in mammography centers located in Medically Underserved areas (MUAs) on the adequacy of diagnostic and treatment services for breast cancer care among underserved women in Chicago. Our primary research outcome will be treatment adequacy and adherence to follow-up care in women with abnormal mammograms, as defined by The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines. This work will extend that of the ongoing comparative effectiveness research evaluating patient navigation in breast cancer care in a randomized clinical trial, in which the primary outcome is time to diagnostic resolution and treatment (Warnecke/Calhoun, P50CA106743-05; Project #1, PI: Calhoun; end date: 6/15/15). In conjunction with the existing patient navigation research project, the proposed research effort will examine comparative effectiveness of patient navigation intervention on two primary outcomes among women with abnormal mammograms (with and without breast cancer): 1) adequacy and quality of follow-up care; and 2) patient's adherence to follow-up care and treatment. The two primary hypotheses are: H 1) Navigated patients with abnormal screening results will be more likely to receive adequate diagnostic evaluations and treatment as compared to usual standard of care. H 2) Navigated patients diagnosed with breast cancer will be more likely to complete appropriate follow-up care and treatment as compared to usual standard of care. In carrying out the research project, training, data, and dissemination core activities aim to enhance scientific
capital, data infrastructure, and dissemination of research findings to eliminate breast disparities.
描述(由申请人提供):此竞争性修订申请支持消除差异的比较有效性研究(CERED)的发展,其中包括四个CERED核心:研究,培训,数据基础设施和传播。该研究项目的目标是评估在医疗服务不足地区(MUAs)的乳房x光检查中心实施的以医院为基础的患者导航干预策略对芝加哥医疗服务不足妇女乳腺癌护理诊断和治疗服务充分性的有效性。我们的主要研究结果将是根据国家综合癌症网络(NCCN)临床实践指南的定义,对乳房x光检查异常妇女的治疗充分性和随访护理的依从性。这项工作将扩展正在进行的比较有效性研究,在一项随机临床试验中评估乳腺癌护理中的患者导航,其中主要结果是诊断解决和治疗的时间(Warnecke/Calhoun, P50CA106743-05;项目1,PI: Calhoun;结束日期:6/15/15)。结合现有的患者导航研究项目,拟议的研究工作将检验患者导航干预对乳房x光检查异常妇女(有或没有乳腺癌)的两个主要结果的比较有效性:1)随访护理的充分性和质量;2)患者对后续护理治疗的依从性。两个主要假设是:1)与通常的标准护理相比,筛查结果异常的导航患者更有可能接受充分的诊断评估和治疗。2)与通常的标准护理相比,导航诊断为乳腺癌的患者更有可能完成适当的后续护理和治疗。在开展研究项目时,培训、数据和传播的核心活动旨在提高科学水平
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Ann Calhoun其他文献
Elizabeth Ann Calhoun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Ann Calhoun', 18)}}的其他基金
Implementation Science and Equity: Community Engagement & Outreach (CEO) Core
实施科学与公平:社区参与
- 批准号:
10557511 - 财政年份:2023
- 资助金额:
$ 140万 - 项目类别:
相似海外基金
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 140万 - 项目类别:
Research Grant
From single-cell transcriptomic to single-cell fluxomic: characterising metabolic dysregulations for breast cancer subtype classification
从单细胞转录组到单细胞通量组:表征乳腺癌亚型分类的代谢失调
- 批准号:
EP/Y001613/1 - 财政年份:2024
- 资助金额:
$ 140万 - 项目类别:
Research Grant
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 140万 - 项目类别:
Launchpad
Quad negative breast cancerに対する新たなプレシジョン・メディシン治療戦略
四阴性乳腺癌精准医学治疗新策略
- 批准号:
24K11748 - 财政年份:2024
- 资助金额:
$ 140万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ESR1 mutation profiling identifies potential drivers of metastatic breast cancer
ESR1 突变分析确定了转移性乳腺癌的潜在驱动因素
- 批准号:
MR/X018199/1 - 财政年份:2024
- 资助金额:
$ 140万 - 项目类别:
Research Grant
Spatial-BrTME: Multicellular spatial dynamics of immunotherapy response in breast cancer
Spatial-BrTME:乳腺癌免疫治疗反应的多细胞空间动力学
- 批准号:
EP/Y014995/1 - 财政年份:2024
- 资助金额:
$ 140万 - 项目类别:
Research Grant
Development of comprehensive PET imaging for precise diagnosis of breast cancer
开发用于乳腺癌精确诊断的综合PET成像
- 批准号:
23H02856 - 财政年份:2023
- 资助金额:
$ 140万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of internal radiation therapy agents for refractory breast cancer based on phase-shift using focused ultrasound
基于聚焦超声相移的难治性乳腺癌体内放射治疗剂的开发
- 批准号:
23H02866 - 财政年份:2023
- 资助金额:
$ 140万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The early detection of breast cancer using field cacerization.
使用现场癌症化早期检测乳腺癌。
- 批准号:
23K08094 - 财政年份:2023
- 资助金额:
$ 140万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of CD44 bearing TJA-II binding glycans in therapy-resistant subset of triple negative breast cancer
携带 CD44 的 TJA-II 结合聚糖在三阴性乳腺癌耐药亚型中的作用
- 批准号:
23K06748 - 财政年份:2023
- 资助金额:
$ 140万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




